Document of interest to medical writers: from lab to patient

This booklet describes the journey of a medicine for human use authorised via the European Medicines Agency (EMA), from initial research to discussions on patient access to medicines across the EU. 

This includes how EMA supports medicine development by providing scientific advice and how it assesses a medicine’s benefits and risks once it receives an application for marketing authorisation.